Literature DB >> 12072562

Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice.

Amanda Sainsbury1, Christoph Schwarzer, Michelle Couzens, Serguei Fetissov, Sabine Furtinger, Arthur Jenkins, Helen M Cox, Günther Sperk, Tomas Hökfelt, Herbert Herzog.   

Abstract

Neuropeptide Y is implicated in energy homeostasis, and contributes to obesity when hypothalamic levels remain chronically elevated. To investigate the specific role of hypothalamic Y2 receptors in this process, we used a conditional Y2 knockout model, using the Cre-lox system and adenoviral delivery of Cre-recombinase. Hypothalamus-specific Y2-deleted mice showed a significant decrease in body weight and a significant increase in food intake that was associated with increased mRNA levels for the orexigenic NPY and AgRP, as well as the anorexic proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) in the arcuate nucleus. These hypothalamic changes persisted until at least 34 days after Y2 deletion, yet the effect on body weight and food intake subsided within this time. Plasma concentrations of pancreatic polypeptide and corticosterone were 3- to 5-fold increased in hypothalamus-specific Y2 knockout mice. Germ-line Y2 receptor knockout also produced a significant increase in plasma levels of pancreatic polypeptide. However, these mice differed from conditional knockout mice in that they showed a sustained reduction in body weight and adiposity associated with increased NPY and AgRP but decreased POMC and CART mRNA levels in the arcuate nucleus. The transience of the observed effects on food intake and body weight in the hypothalamus-specific Y2 knockout mice, and the difference of this model from germ-line Y2 knockout mice, underline the importance of conditional models of gene deletion, because developmental, secondary, or extrahypothalamic mechanisms may mask such effects in germ-line knockouts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072562      PMCID: PMC124402          DOI: 10.1073/pnas.132043299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

Authors:  J C Erickson; G Hollopeter; R D Palmiter
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 2.  Y-receptor subtypes--how many more?

Authors:  A G Blomqvist; H Herzog
Journal:  Trends Neurosci       Date:  1997-07       Impact factor: 13.837

3.  Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

Authors:  A Sainsbury; F Rohner-Jeanrenaud; I Cusin; K E Zakrzewska; P A Halban; R C Gaillard; B Jeanrenaud
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

4.  Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy.

Authors:  C Schwarzer; N Kofler; G Sperk
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

5.  GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy.

Authors:  K Tsunashima; C Schwarzer; E Kirchmair; W Sieghart; G Sperk
Journal:  Neuroscience       Date:  1997-10       Impact factor: 3.590

6.  Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.

Authors:  C Broberger; M Landry; H Wong; J N Walsh; T Hökfelt
Journal:  Neuroendocrinology       Date:  1997-12       Impact factor: 4.914

7.  Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor.

Authors:  T Pedrazzini; J Seydoux; P Künstner; J F Aubert; E Grouzmann; F Beermann; H R Brunner
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

8.  Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor.

Authors:  P M Rose; P Fernandes; J S Lynch; S T Frazier; S M Fisher; K Kodukula; B Kienzle; R Seethala
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

9.  Expression cloning of a human brain neuropeptide Y Y2 receptor.

Authors:  D R Gehlert; L S Beavers; D Johnson; S L Gackenheimer; D A Schober; R A Gadski
Journal:  Mol Pharmacol       Date:  1996-02       Impact factor: 4.436

10.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.

Authors:  J C Erickson; K E Clegg; R D Palmiter
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

View more
  66 in total

Review 1.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

2.  A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.

Authors:  Akane Ishihara; Akio Kanatani; Satoshi Mashiko; Takeshi Tanaka; Masayasu Hidaka; Akira Gomori; Hisashi Iwaasa; Naomi Murai; Shin-ichiro Egashira; Takashi Murai; Yuko Mitobe; Hiroko Matsushita; Osamu Okamoto; Nagaaki Sato; Makoto Jitsuoka; Takahiro Fukuroda; Tomoyuki Ohe; Xiaoming Guan; Douglas J MacNeil; Lex H T Van der Ploeg; Masaru Nishikibe; Yasuyuki Ishii; Masaki Ihara; Takehiro Fukami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 3.  Electrophysiological analysis of circuits controlling energy homeostasis.

Authors:  Masoud Ghamari-Langroudi
Journal:  Mol Neurobiol       Date:  2012-02-14       Impact factor: 5.590

4.  The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression.

Authors:  Ramon O Tasan; Ngoc Khoi Nguyen; Stefan Weger; Simone B Sartori; Nicolas Singewald; Regine Heilbronn; Herbert Herzog; Günther Sperk
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 5.  Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota.

Authors:  Paige V Bauer; Sophie C Hamr; Frank A Duca
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

Review 6.  The obesity of bone.

Authors:  Emanuela A Greco; Andrea Lenzi; Silvia Migliaccio
Journal:  Ther Adv Endocrinol Metab       Date:  2015-12       Impact factor: 3.565

7.  Gene array profiling of large hypothalamic CNS regions in lactating and randomly cycling virgin mice.

Authors:  Stephen C Gammie; Nina S Hasen; Tarif A Awad; Anthony P Auger; Heather M Jessen; Jules B Panksepp; Anne M Bronikowski
Journal:  Brain Res Mol Brain Res       Date:  2005-10-03

8.  GABAergic Inputs to POMC Neurons Originating from the Dorsomedial Hypothalamus Are Regulated by Energy State.

Authors:  Andrew R Rau; Shane T Hentges
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

9.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

10.  Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice.

Authors:  Amanda Sainsbury; Paul A Baldock; Christoph Schwarzer; Naohiko Ueno; Ronaldo F Enriquez; Michelle Couzens; Akio Inui; Herbert Herzog; Edith M Gardiner
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.